Genomic Health, Inc. (NASDAQ:GHDX)
CAPS Rating:
A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.
RSS Headlines
Fool UK
Recs
Good mgmt, mgmt have skin in the game, growing field, great execution in building payment from insurance companies.